Analysis shows revised FIGO staging affects survival outcomes in cervical cancer, suggesting refinements needed for treatment.
The FIGO 2018 staging effectively reflects survival variation in cervical cancer. Notably, stage IIIC1 had better outcomes than IIIB, while IIIC2 had worse outcomes compared to IVA. Further studies are needed to refine treatment for node-positive disease.
No takes yet. Share an insight, caveat, or question.
Sindhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: